Dr. Bander gives an overview of PSMA-PET imaging innovations

“It's very clear that PSMA-PET imaging is having…a transformative impact on our ability to image metastatic disease, in that it is much more sensitive than we've had for the last 50 plus years—and also, 98% specific,” says Neil H. Bander, MD.

In this video, Neil H. Bander, MD, discusses innovations in PSMA-PET imaging for patients with prostate cancer and how these breakthroughs will change diagnosis and treatment. Bander is the Bernard & Josephine Chaus professor of Urologic Oncology at Weill Cornell Medicine, New York City, New York.